Report Detail

Pharma & Healthcare Global Veterinary Drugs Market Insights and Forecast to 2026

  • RnM4130910
  • |
  • 12 August, 2020
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Veterinary Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Veterinary Drugs market is segmented into
Anti-Infective
Anti-Inflammatory
Parasiticides
Others

Segment by Application, the Veterinary Drugs market is segmented into
Companion Animal
Livestock Animal

Regional and Country-level Analysis
The Veterinary Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Veterinary Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Veterinary Drugs Market Share Analysis
Veterinary Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Veterinary Drugs business, the date to enter into the Veterinary Drugs market, Veterinary Drugs product introduction, recent developments, etc.

The major vendors covered:
Boehringer Ingelheim
Bayer AG
Elanco Animal Health (Eli Lilly and Company)
Ceva Sant Animale
Dechra Pharmaceuticals PLC.
Merck Animal Health
Virbac
Vetoquinol


1 Study Coverage

  • 1.1 Veterinary Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Veterinary Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Veterinary Drugs Market Size Growth Rate by Type
    • 1.4.2 Anti-Infective
    • 1.4.3 Anti-Inflammatory
    • 1.4.4 Parasiticides
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Veterinary Drugs Market Size Growth Rate by Application
    • 1.5.2 Companion Animal
    • 1.5.3 Livestock Animal
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Veterinary Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Veterinary Drugs Revenue 2015-2026
    • 2.1.2 Global Veterinary Drugs Sales 2015-2026
  • 2.2 Global Veterinary Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Veterinary Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Veterinary Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Veterinary Drugs Competitor Landscape by Players

  • 3.1 Veterinary Drugs Sales by Manufacturers
    • 3.1.1 Veterinary Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Veterinary Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Veterinary Drugs Revenue by Manufacturers
    • 3.2.1 Veterinary Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Veterinary Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Veterinary Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Veterinary Drugs Revenue in 2019
    • 3.2.5 Global Veterinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Veterinary Drugs Price by Manufacturers
  • 3.4 Veterinary Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Veterinary Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Veterinary Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Veterinary Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Veterinary Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Veterinary Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Veterinary Drugs Revenue by Type (2015-2020)
    • 4.1.3 Veterinary Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Veterinary Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Veterinary Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Veterinary Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Veterinary Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Veterinary Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Veterinary Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Veterinary Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Veterinary Drugs Revenue by Application (2015-2020)
    • 5.1.3 Veterinary Drugs Price by Application (2015-2020)
  • 5.2 Veterinary Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Veterinary Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Veterinary Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Veterinary Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Veterinary Drugs by Country
    • 6.1.1 North America Veterinary Drugs Sales by Country
    • 6.1.2 North America Veterinary Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Veterinary Drugs Market Facts & Figures by Type
  • 6.3 North America Veterinary Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Veterinary Drugs by Country
    • 7.1.1 Europe Veterinary Drugs Sales by Country
    • 7.1.2 Europe Veterinary Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Veterinary Drugs Market Facts & Figures by Type
  • 7.3 Europe Veterinary Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Veterinary Drugs by Region
    • 8.1.1 Asia Pacific Veterinary Drugs Sales by Region
    • 8.1.2 Asia Pacific Veterinary Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Veterinary Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Veterinary Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Veterinary Drugs by Country
    • 9.1.1 Latin America Veterinary Drugs Sales by Country
    • 9.1.2 Latin America Veterinary Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Veterinary Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Veterinary Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Veterinary Drugs by Country
    • 10.1.1 Middle East and Africa Veterinary Drugs Sales by Country
    • 10.1.2 Middle East and Africa Veterinary Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Veterinary Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Veterinary Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Boehringer Ingelheim
    • 11.1.1 Boehringer Ingelheim Corporation Information
    • 11.1.2 Boehringer Ingelheim Description and Business Overview
    • 11.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Boehringer Ingelheim Veterinary Drugs Products Offered
    • 11.1.5 Boehringer Ingelheim Related Developments
  • 11.2 Bayer AG
    • 11.2.1 Bayer AG Corporation Information
    • 11.2.2 Bayer AG Description and Business Overview
    • 11.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bayer AG Veterinary Drugs Products Offered
    • 11.2.5 Bayer AG Related Developments
  • 11.3 Elanco Animal Health (Eli Lilly and Company)
    • 11.3.1 Elanco Animal Health (Eli Lilly and Company) Corporation Information
    • 11.3.2 Elanco Animal Health (Eli Lilly and Company) Description and Business Overview
    • 11.3.3 Elanco Animal Health (Eli Lilly and Company) Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Elanco Animal Health (Eli Lilly and Company) Veterinary Drugs Products Offered
    • 11.3.5 Elanco Animal Health (Eli Lilly and Company) Related Developments
  • 11.4 Ceva Sant Animale
    • 11.4.1 Ceva Sant Animale Corporation Information
    • 11.4.2 Ceva Sant Animale Description and Business Overview
    • 11.4.3 Ceva Sant Animale Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Ceva Sant Animale Veterinary Drugs Products Offered
    • 11.4.5 Ceva Sant Animale Related Developments
  • 11.5 Dechra Pharmaceuticals PLC.
    • 11.5.1 Dechra Pharmaceuticals PLC. Corporation Information
    • 11.5.2 Dechra Pharmaceuticals PLC. Description and Business Overview
    • 11.5.3 Dechra Pharmaceuticals PLC. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Dechra Pharmaceuticals PLC. Veterinary Drugs Products Offered
    • 11.5.5 Dechra Pharmaceuticals PLC. Related Developments
  • 11.6 Merck Animal Health
    • 11.6.1 Merck Animal Health Corporation Information
    • 11.6.2 Merck Animal Health Description and Business Overview
    • 11.6.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Merck Animal Health Veterinary Drugs Products Offered
    • 11.6.5 Merck Animal Health Related Developments
  • 11.7 Virbac
    • 11.7.1 Virbac Corporation Information
    • 11.7.2 Virbac Description and Business Overview
    • 11.7.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Virbac Veterinary Drugs Products Offered
    • 11.7.5 Virbac Related Developments
  • 11.8 Vetoquinol
    • 11.8.1 Vetoquinol Corporation Information
    • 11.8.2 Vetoquinol Description and Business Overview
    • 11.8.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Vetoquinol Veterinary Drugs Products Offered
    • 11.8.5 Vetoquinol Related Developments
  • 11.1 Boehringer Ingelheim
    • 11.1.1 Boehringer Ingelheim Corporation Information
    • 11.1.2 Boehringer Ingelheim Description and Business Overview
    • 11.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Boehringer Ingelheim Veterinary Drugs Products Offered
    • 11.1.5 Boehringer Ingelheim Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Veterinary Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Veterinary Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Veterinary Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Veterinary Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Veterinary Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Veterinary Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Veterinary Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Veterinary Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Veterinary Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Veterinary Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Veterinary Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Veterinary Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Veterinary Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Veterinary Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Veterinary Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Veterinary Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Veterinary Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Veterinary Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Veterinary Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Veterinary Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Veterinary Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Veterinary Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Veterinary Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Veterinary Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Veterinary Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Veterinary Drugs. Industry analysis & Market Report on Veterinary Drugs is a syndicated market report, published as Global Veterinary Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Veterinary Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,069.30
    4,603.95
    6,138.60
    3,591.90
    5,387.85
    7,183.80
    609,219.00
    913,828.50
    1,218,438.00
    324,987.00
    487,480.50
    649,974.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report